These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1285 related items for PubMed ID: 19453647

  • 1. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL, SMART Study Group.
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [Abstract] [Full Text] [Related]

  • 2. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
    van de Woestijne AP, van der Graaf Y, Liem AH, Cramer MJ, Westerink J, Visseren FL, SMART Study Group.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1834-41. PubMed ID: 23948286
    [Abstract] [Full Text] [Related]

  • 3. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 12; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA, Kaouache M, Joseph L, Barter P, Davignon J.
    Arch Intern Med; 2009 Oct 26; 169(19):1775-80. PubMed ID: 19858435
    [Abstract] [Full Text] [Related]

  • 5. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A, LIPID Study Investigators.
    Eur Heart J; 2004 May 26; 25(9):771-7. PubMed ID: 15120888
    [Abstract] [Full Text] [Related]

  • 6. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

  • 7. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 10; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 8. Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol.
    van de Woestijne AP, Wassink AM, Monajemi H, Liem AH, Nathoe HM, van der Graaf Y, Visseren FL, SMART study group.
    Int J Cardiol; 2013 Jul 31; 167(2):403-8. PubMed ID: 22265582
    [Abstract] [Full Text] [Related]

  • 9. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G, Targher G, Chonchol M, Perrone F, Lippi G, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2009 Oct 31; 19(8):580-6. PubMed ID: 19196499
    [Abstract] [Full Text] [Related]

  • 10. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 31; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 11. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM.
    Am Heart J; 2006 Mar 31; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [Abstract] [Full Text] [Related]

  • 12. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug 31; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 13. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ, Yellon DM.
    Heart; 2008 Jun 31; 94(6):706-14. PubMed ID: 18480348
    [Abstract] [Full Text] [Related]

  • 14. Relationship between plasma lipids and all-cause mortality in nondemented elderly.
    Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R.
    J Am Geriatr Soc; 2005 Feb 31; 53(2):219-26. PubMed ID: 15673344
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of lipoprotein fractions in essential hypertension.
    Verdecchia P, Reboldi G, Angeli F, Gattobigio R, Borgioni C, Filippucci L, Poeta F, Porcellati C.
    Blood Press; 2004 Feb 31; 13(5):295-303. PubMed ID: 15545153
    [Abstract] [Full Text] [Related]

  • 16. Gender differences in the lipid profile of dyslipidemic subjects.
    Kolovou GD, Anagnostopoulou KK, Damaskos DS, Bilianou HI, Mihas C, Milionis HJ, Kostakou PM, Cokkinos DV.
    Eur J Intern Med; 2009 Mar 31; 20(2):145-51. PubMed ID: 19327602
    [Abstract] [Full Text] [Related]

  • 17. The emergence of triglycerides as a significant independent risk factor in coronary artery disease.
    Assmann G, Schulte H, Funke H, von Eckardstein A.
    Eur Heart J; 1998 Oct 31; 19 Suppl M():M8-14. PubMed ID: 9821011
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF.
    Arterioscler Thromb Vasc Biol; 2008 Jun 31; 28(6):1172-8. PubMed ID: 18356553
    [Abstract] [Full Text] [Related]

  • 19. Low high-density lipoprotein cholesterol as the possible risk factor for stroke.
    Demarin V, Lisak M, Morović S, Cengić T.
    Acta Clin Croat; 2010 Dec 31; 49(4):429-39. PubMed ID: 21830454
    [Abstract] [Full Text] [Related]

  • 20. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 31; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 65.